Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.

Angiogenesis is not only dependent on endothelial cell invasion and proliferation, it also requires pericyte coverage of vascular sprouts for stabilization of vascular walls. Clinical efficacy of angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) signaling pathway is sti...

Bibliográfalaš dieđut
Váldodahkkit:	Helfrich, I, Scheffrahn, I, Bartling, S, Weis, J, von Felbert, V, Middleton, M, Kato, M, Ergün, S, Augustin, H, Schadendorf, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2010

Geahča maid

Malignant melanoma and fluorescent lighting.
Dahkki: Carlton-Foss, J
Almmustuhtton: (1982)

Malignant melanoma and bone resorption.
Dahkki: Lau, Y, et al.
Almmustuhtton: (2006)

Melanocyte development and malignant melanoma.
Dahkki: Goding, C
Almmustuhtton: (2000)

Lymphangiogenesis and metastasis in malignant melanoma
Dahkki: Shields, J, et al.
Almmustuhtton: (2003)

Angioarchitecture of primary oral malignant melanomas
Dahkki: Lee, Y.J., et al.
Almmustuhtton: (2002)

Toward automated detection of malignant melanoma
Dahkki: Huang, Billy, et al.
Almmustuhtton: (2010)

MALIGNANT-MELANOMA AND FLUORESCENT LIGHTING - REPLY
Dahkki: Beral, V, et al.
Almmustuhtton: (1982)

Angiogenesis and antiangiogenic therapy in endometriosis.
Dahkki: Becker, C, et al.
Almmustuhtton: (2007)

Antiangiogenic effects of somatostatin analogues.
Dahkki: García de la Torre, N, et al.
Almmustuhtton: (2002)

Malignant Melanoma of Oesophagus: A Rare Entity
Dahkki: Mohamed Arif Bin Hameed Sultan, et al.
Almmustuhtton: (2023)

Malignant Melanoma of Oesophagus: A Rare Entity
Dahkki: Mohamed Arif Bin Hameed Sultan, et al.
Almmustuhtton: (2022)

Primary Malignant Melanoma of Vagina: The Options of Management.
Dahkki: Ng, BK, et al.
Almmustuhtton: (2014)

Role of primary care in the prevention of malignant melanoma.
Dahkki: Johnson, N, et al.
Almmustuhtton: (1994)

Malignant melanoma and exposure to fluorescent lighting at work.
Dahkki: Beral, V, et al.
Almmustuhtton: (1982)

Oral contraceptive use and malignant melanoma in Australia.
Dahkki: Beral, V, et al.
Almmustuhtton: (1984)

Malignant melanoma and exposure to fluorescent lighting at work.
Dahkki: Stern, R
Almmustuhtton: (1982)

Cutaneous factors related to the risk of malignant melanoma.
Dahkki: Beral, V, et al.
Almmustuhtton: (1983)

Transcriptional control of phenotype in melanoma
Dahkki: Mosteo López, L
Almmustuhtton: (2019)

Allele loss on chromosome 11q and microsatellite instability in malignant melanoma.
Dahkki: Tomlinson, I, et al.
Almmustuhtton: (1996)

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma
Dahkki: Hemstock, M, et al.
Almmustuhtton: (2020)

Malignant melanoma of the uterus: a rare cause of postmenopausal bleeding
Dahkki: Abdul Hamid, Habibah, et al.
Almmustuhtton: (2017)

Malignant melanoma and oral contraceptive use among women in California.
Dahkki: Beral, V, et al.
Almmustuhtton: (1977)

Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma
Dahkki: Taylor, N, et al.
Almmustuhtton: (2016)

Preclinical evaluation of discorhabdin in antiangiogenic and antitumor models
Dahkki: Harris, E, et al.
Almmustuhtton: (2018)

Connecting metabolic rewiring with phenotype switching in melanoma
Dahkki: Falletta, P, et al.
Almmustuhtton: (2022)

Emphysematous gastritis after metastatic malignant melanoma: a radiological surprise
Dahkki: Ng, Chiak Yot, et al.
Almmustuhtton: (2020)

A distinct octamer-binding protein present in malignant melanoma cells.
Dahkki: Cox, P, et al.
Almmustuhtton: (1988)

Type 1 insulin-like growth factor signalling in malignant melanoma
Dahkki: Goodfellow, M, et al.
Almmustuhtton: (2012)

Antiangiogenic therapy in oncology: current status and future directions
Dahkki: Jayson, G, et al.
Almmustuhtton: (2016)

Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas.
Dahkki: Rowan, A, et al.
Almmustuhtton: (1999)

Circulating melanoma cells and survival in metastatic melanoma.
Dahkki: Rao, C, et al.
Almmustuhtton: (2011)

Association of incident amelanotic melanoma with phenotypic characteristics, MC1R status, and prior amelanotic melanoma
Dahkki: Vernali, S, et al.
Almmustuhtton: (2017)

Cancer stem cells versus phenotype-switching in melanoma.
Dahkki: Hoek, K, et al.
Almmustuhtton: (2010)

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
Dahkki: Rambow, F, et al.
Almmustuhtton: (2019)

The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work.
Dahkki: Beral, V, et al.
Almmustuhtton: (1981)

A population-based study on the familial aggregation of cutaneous malignant melanoma in Iceland.
Dahkki: Eldon, B, et al.
Almmustuhtton: (2006)

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4
Dahkki: Harjes, U, et al.
Almmustuhtton: (2016)

Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers.
Dahkki: Tomlinson, I, et al.
Almmustuhtton: (1993)

Solarium use and risk for malignant melanoma: meta-analysis and evidence-based medicine systematic review
Dahkki: Burgard, B, et al.
Almmustuhtton: (2018)

An update on solarium use and risk for malignant melanoma: a critical systematic review and meta-analysis
Dahkki: Burgard, B, et al.
Almmustuhtton: (2017)